Femto Technologies Inc., a Nasdaq-listed Femtech innovator, has secured a Notice of Allowance from the U.S. Patent and Trademark Office for its proprietary Smart Release System (SRS) technology. This milestone underscores the company's commitment to advancing AI-driven wellness solutions in the feminine health sector.
The Smart Release System technology is a key component of Sensera, a feminine wellness device that recently earned a CES Innovation Awards® 2025 honoree designation in the AI category. By integrating machine learning and artificial intelligence, Sensera aims to provide a personalized and adaptive approach to women's wellness.
CEO Yftah Ben Yaackov highlighted the significance of the patent, emphasizing the technology's potential to drive transformative advancements in Femtech. The patent represents a critical validation of Femto's research and development efforts, positioning the company at the forefront of innovative wellness technologies.
The Smart Release System technology has broad applications across Femto's product development strategy. The company remains dedicated to rigorous testing, research, and regulatory compliance to ensure product efficacy and safety.
This patent represents more than a legal milestone; it signals the growing intersection of artificial intelligence and personalized healthcare. By developing AI-driven solutions that adapt to individual needs, Femto Technologies is helping to reshape how technology can support and enhance personal wellness.
